Total Payments
$56,382
2024 Payments
$892.27
Companies
42
Transactions
540
Medicare Patients
122
Medicare Billing
$41,528
Payment Breakdown by Category
Other$45,778 (81.2%)
Food & Beverage$8,769 (15.6%)
Travel$1,601 (2.8%)
Education$233.38 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,778 | 26 | 81.2% |
| Food and Beverage | $8,769 | 500 | 15.6% |
| Travel and Lodging | $1,601 | 6 | 2.8% |
| Education | $233.38 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $48,740 | 118 | $0 (2024) |
| Animas Corporation | $1,606 | 134 | $0 (2017) |
| AbbVie Inc. | $807.38 | 32 | $0 (2023) |
| Ascendis Pharma Inc | $758.29 | 28 | $0 (2024) |
| Mannkind Corporation | $609.38 | 37 | $0 (2024) |
| Sandoz Inc. | $463.42 | 24 | $0 (2020) |
| Insulet Corporation | $307.58 | 14 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $263.83 | 14 | $0 (2022) |
| Lilly USA, LLC | $244.46 | 13 | $0 (2019) |
| Xeris Pharmaceuticals, Inc. | $238.25 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $892.27 | 35 | Ascendis Pharma Inc ($220.66) |
| 2023 | $966.06 | 42 | Ascendis Pharma Inc ($319.16) |
| 2022 | $734.98 | 32 | Ascendis Pharma, Inc. ($218.47) |
| 2021 | $940.26 | 51 | MannKind Corporation ($217.93) |
| 2020 | $631.40 | 32 | Xeris Pharmaceuticals, Inc. ($163.88) |
| 2019 | $3,993 | 50 | Novo Nordisk Inc ($3,296) |
| 2018 | $21,209 | 71 | Novo Nordisk Inc ($20,444) |
| 2017 | $27,014 | 227 | Novo Nordisk Inc ($24,647) |
All Payment Transactions
540 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/31/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Growth Hormone | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/04/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Endocrinology | ||||||
| 09/11/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/05/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Hyperthyroidism | ||||||
| 09/03/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 08/15/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Endocrinology | ||||||
| 08/08/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Growth Hormone | ||||||
| 08/02/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 08/01/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/30/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Endocrinology | ||||||
| 07/11/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Automated insulin delivery system | ||||||
| 06/18/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Endocrinology | ||||||
| 06/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $125.60 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/23/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Endocrinology | ||||||
| 05/16/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/02/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/02/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 36 | 125 | $27,500 | $12,112 |
| 2022 | 1 | 28 | 89 | $19,580 | $8,796 |
| 2021 | 1 | 25 | 99 | $21,780 | $9,833 |
| 2020 | 1 | 33 | 131 | $28,820 | $10,787 |
Total Patients
122
Total Services
444
Medicare Billing
$41,528
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 125 | $27,500 | $12,112 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 89 | $19,580 | $8,796 | 44.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 99 | $21,780 | $9,833 | 45.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 131 | $28,820 | $10,787 | 37.4% |
About Dr. Tseghai Berhe, MD
Dr. Tseghai Berhe, MD is a Pediatric Endocrinology healthcare provider based in Schaumburg, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982678207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tseghai Berhe, MD has received a total of $56,382 in payments from pharmaceutical and medical device companies, with $892.27 received in 2024. These payments were reported across 540 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,778).
As a Medicare-enrolled provider, Berhe has provided services to 122 Medicare beneficiaries, totaling 444 services with total Medicare billing of $41,528. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Schaumburg, IL
- Active Since 02/14/2006
- Last Updated 01/30/2026
- Taxonomy Code 2080P0205X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982678207
Products in Payments
- Norditropin (Drug) $48,155
- OneTouch (Device) $1,638
- AFREZZA (Drug) $609.38
- SKYTROFA (Drug) $537.63
- OMNITROPE (Drug) $463.42
- Omnipod (Device) $307.58
- FENSOLVI (Drug) $284.42
- Crysvita (Drug) $254.25
- GENOTROPIN (Drug) $223.34
- HUMATROPE (Drug) $223.10
- Skytrofa (Drug) $220.66
- GVOKE PFS (Drug) $217.49
- Synthroid (Drug) $201.76
- TZIELD (Biological) $197.39
- LUPRON DEPOT (Drug) $185.73
- Sogroya (Biological) $165.12
- Dexcom G6 Transmitter (Medical Supply) $128.79
- Lupron (Drug) $124.08
- ZOMACTON (Drug) $118.75
- INTELLIS ADAPTIVESTIM (Device) $106.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.